Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion type Assertion NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_head.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion description "[Here, we use a genetically engineered mouse model of BRCA2-associated hereditary breast cancer to study drug resistance to several types of chemotherapy and PARP inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_provenance.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion evidence source_evidence_literature NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_provenance.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion SIO_000772 25511378 NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_provenance.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion wasDerivedFrom befree-2016 NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_provenance.
- NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_assertion wasGeneratedBy ECO_0000203 NP1248330.RA8ghM8zFQiGnKY_cm1qQ2glem_n5XPtPJYDZrwqOA0fY130_provenance.